Adicet Bio, Inc. Increase (Decrease) in Restricted Cash
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Restricted Cash of $161.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2019-11-05
- Adicet Bio, Inc. increase (decrease) in restricted cash for the quarter ending 2019-09-30 was $0.00.
- Adicet Bio, Inc. increase (decrease) in restricted cash for the quarter ending 2018-12-31 was $0.00.
- Adicet Bio, Inc. increase (decrease) in restricted cash for the quarter ending 2018-09-30 was $0.00.
- Adicet Bio, Inc. increase (decrease) in restricted cash for the quarter ending 2018-06-30 was $0.00.
- Adicet Bio, Inc. increase (decrease) in restricted cash for fiscal 2018 was $84.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $161.00K 10-Q · filed 2019-11-05 | ||
| 2019-06-30 | $161.00K 10-Q · filed 2019-08-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 derived: sum of 3 quarters · filed 2019-11-05 | $84.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $84.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $84.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $84.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |